Psychemedics grants 300,000 inducement options to new CEO; Nevin elected Chairman

PSYCHEMEDICS CORP

Inducement options to purchase 300,000 shares granted to CEO Brian Hullinger at $4.65/share exercise price.
Options vest in three tranches: 100,000 time-based over 2 years; 200,000 performance-based on stock price targets.
Darius G. Nevin elected Chairman of the Board, succeeding Raymond C. Kubacki who retired on August 17, 2023.
Annual meeting results: All six director nominees elected; advisory vote on exec compensation approved; BDO USA ratified as auditor.

item 5.02 item 5.07 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

PSYCHEMEDICS CORP shareholders approved Election of six directors to serve until the 2024 Annual Meeting.

Proposal: director election
Outcome: passed

Exact text from the filing

Proposal No. 1. Election of Directors. The stockholders elected six directors to serve until the Company's 2024 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, by the votes set forth in the table below: Nominees For Withheld Broker Non-Votes Robyn C. Davis 2,898,919 140,670 1,228,741 Brian Hullinger 2,996,505 43,084 1,228,741 Peter H. Kamin 2,974,032 65,557 1,228,741 Darius G. Nevin 2,938,911 100,678 1,228,741 Andrew M. Reynolds 2,805,910 233,679 1,228,741

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

PSYCHEMEDICS CORP shareholders approved Advisory vote on executive compensation.

Proposal: say on pay
Outcome: passed

Exact text from the filing

Proposal No. 2. Advisory Vote on Executive Compensation. The stockholders approved a non-binding advisory resolution to approve executive compensation, as described in the Proxy Statement, by the votes set forth in the table below: For Against Abstain Broker Non-Votes 2,855,077 170,531 13,981 1,228,741

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

PSYCHEMEDICS CORP shareholders approved Ratification of appointment of BDO USA, P.A. as independent registered public accounting firm at the 2023-12-31 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-12-31

Exact text from the filing

Proposal No. 3. Ratification of Appointment of Independent Registered Public Accounting Firm. The stockholders ratified the appointment of BDO USA, P.A. as the Company's independent registered public accounting firm for the year ending December 31, 2023, by the votes set forth in the table below: For Against Abstain Broker Non-Votes 4,223,842 36,638 7,850 0

View on SEC.gov

Browse all shareholder votes →

PSYCHEMEDICS CORP filing history →

Source: SEC EDGAR

accession 0001171843-23-005387

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.